Celik, S. Et Al. 2023. Recombinant anti-Mullerian hormone treatment attenuates primordial follicle loss after ovarian cryopreservation and transplantation. Journal of Assisted Reproduction and Genetics , vol.40, no.5 , 1117-1134.

Celik, S., Ozkavukcu, S., & Celik-Ozenci, C., (2023). Recombinant anti-Mullerian hormone treatment attenuates primordial follicle loss after ovarian cryopreservation and transplantation. Journal of Assisted Reproduction and Genetics , vol.40, no.5, 1117-1134.

Celik, SONER, Sinan Ozkavukcu, And Ciler Celik-Ozenci. "Recombinant anti-Mullerian hormone treatment attenuates primordial follicle loss after ovarian cryopreservation and transplantation," Journal of Assisted Reproduction and Genetics , vol.40, no.5, 1117-1134, 2023

Celik, SONER Et Al. "Recombinant anti-Mullerian hormone treatment attenuates primordial follicle loss after ovarian cryopreservation and transplantation." Journal of Assisted Reproduction and Genetics , vol.40, no.5, pp.1117-1134, 2023

Celik, S. Ozkavukcu, S. And Celik-Ozenci, C. (2023) . "Recombinant anti-Mullerian hormone treatment attenuates primordial follicle loss after ovarian cryopreservation and transplantation." Journal of Assisted Reproduction and Genetics , vol.40, no.5, pp.1117-1134.

@article{article, author={SONER ÇELİK Et Al. }, title={Recombinant anti-Mullerian hormone treatment attenuates primordial follicle loss after ovarian cryopreservation and transplantation}, journal={Journal of Assisted Reproduction and Genetics}, year=2023, pages={1117-1134} }